title: Is total gastrectomy still acceptable in the treatment of the Zollinger-Ellison syndrome?
authors.forename: M F
authors.initials: MF
authors.lastname: Brennan
authors.forename: A P
authors.initials: AP
authors.lastname: Sloan
authors.forename: S R
authors.initials: SR
authors.lastname: Friesen
authors.forename: H J
authors.initials: HJ
authors.lastname: Peiper
authors.forename: W
authors.initials: W
authors.lastname: Creutzfeldt
authors.forename: J C
authors.initials: JC
authors.lastname: Thompson
authors.forename: R M
authors.initials: RM
authors.lastname: Zollinger
authors.forename: J R
authors.initials: JR
authors.lastname: Siewert
mesh_terms: D003131:Combined Modality Therapy; D005743:Gastrectomy; D005744:Gastric Acid / Q000378:metabolism; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D011379:Prognosis; D013274:Stomach Neoplasms / Q000601:surgery*; D014629:Vagotomy, Proximal Gastric; D015043:Zollinger-Ellison Syndrome / Q000601:surgery*
chemical_list: D006635:Histamine H2 Antagonists